Global Normothermic Organ Perfusion Systems for Transplantation Market Growth 2026-2032
The global Normothermic Organ Perfusion Systems for Transplantation market size is predicted to grow from US$ 500 million in 2025 to US$ 1486 million in 2032; it is expected to grow at a CAGR of 16.1% from 2026 to 2032.
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
Key FindingsIn 2025, the average selling price of commercial normothermic organ perfusion systems worldwide was approximately US$150,000–250,000 per unit.The industry’s overall gross margin remained at approximately 55%–70% in 2025.Liver normothermic perfusion remained the largest commercial organ segment.North America remained the largest value market globally.Organ preservation and transplant preparation remained the largest application segment.
Market Trends
The principal technology trend is the transition from passive preservation toward active organ management. Normothermic perfusion maintains donor organs in a functioning or near-functioning physiological state and creates a time window in which clinicians can observe hemodynamic, metabolic and organ-specific parameters before implantation. This is changing the role of preservation technology from simple time extension to a broader combination of preservation, functional assessment and potentially therapeutic intervention. The commercial direction is also shifting toward organ-specific protocols built on common platform architectures, enabling manufacturers to leverage pumps, monitoring, temperature control, software and disposable technologies across multiple transplant indications.
A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
Market Dynamics
Drivers
The central market driver is the persistent shortage of transplantable donor organs. U.S. transplant activity reached 46,750 solid-organ procedures in 2024, while 167,230 unique patients were present on transplant waiting lists during the year. At the same time, a meaningful proportion of recovered organs remain unused, including 29.3% of recovered kidneys and 11.3% of recovered lungs in 2024. Technologies that can provide functional assessment and improve confidence in marginal or DCD organs therefore have a direct clinical and economic rationale.
Restraints
High equipment and procedure-related costs remain the principal restraint. Commercial NMP requires not only a perfusion console but also organ-specific disposable sets, perfusion solutions, trained personnel and workflow integration. Adoption is consequently concentrated in high-volume transplant centers and healthcare systems capable of supporting specialized operating procedures and reimbursement requirements. Clinical evidence and regulatory approvals are also organ-specific, limiting the ability of manufacturers to transfer commercial success from one organ indication directly to another.
Opportunities
The largest structural opportunity lies in increasing utilization of organs that would otherwise be declined. DCD transplantation, extended-criteria donors, longer-distance donor recovery and objective viability assessment all enlarge the addressable procedure pool without requiring a proportional increase in donor availability. Kidney transplantation represents an especially significant longer-term opportunity because kidney transplant volumes are substantially larger than liver, heart or lung volumes, while current commercial NMP penetration remains limited. Next-generation platforms incorporating automation, continuous data collection and remote monitoring could also reduce operating complexity and extend the technology beyond a relatively small group of specialist centers.
Challenges
The industry must demonstrate that higher preservation costs translate into improved organ utilization, clinical outcomes or transplant-center productivity. Evidence requirements are substantial because performance must be established separately across organs, donor populations and clinical protocols. Operational reliability is also critical: the equipment supports viable donor organs during time-sensitive transplantation processes, so pump failure, temperature instability, disposable-set problems or logistical interruptions can carry unusually high consequences. Scaling manufacturing and clinical-support capacity while maintaining quality systems is therefore a major barrier for emerging suppliers.
Industry Chain Analysis
The upstream industry includes medical-grade pumps, oxygenators, heat exchangers, pressure and flow sensors, temperature-control components, sterile tubing, organ chambers, electronic control systems, embedded software and pharmaceutical-grade perfusion solutions. Because the system operates directly with transplantable organs, suppliers must meet stringent requirements for biocompatibility, sterility, reliability and traceability. Manufacturers typically retain control over core console design, organ-specific disposable circuits, software algorithms and clinical protocols, while sourcing selected pumps, sensors, plastics and electronic components from qualified medical-device supply chains.
The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
Value Chain Analysis
Value creation is concentrated less in conventional hardware manufacturing than in proprietary organ-specific perfusion protocols, clinical evidence, regulatory approvals, disposable ecosystems and transplant-center integration. Reusable consoles can be sold, leased or placed to accelerate installed-base expansion, while recurring disposable perfusion sets and dedicated solutions provide a more scalable source of revenue. XVIVO explicitly identifies disposable sales rather than machines as the primary profitability driver in both its thoracic and abdominal businesses, illustrating the importance of procedure-linked recurring consumption.
The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
Segment Insights
By target organ, liver represents the largest commercial segment, followed by heart and lung, while kidney NMP remains a comparatively early commercial opportunity. Liver NMP has established a particularly strong clinical proposition because viability can be assessed through multiple functional and biochemical indicators and because DCD liver transplantation has expanded rapidly. Heart perfusion represents a high-value application where transport time and DCD utilization are central considerations, while lung perfusion benefits from the established concept of ex vivo lung assessment. Kidney transplantation provides the largest procedure base but currently relies heavily on cold storage and hypothermic machine perfusion, leaving substantial room for NMP development.
By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Downstream Market Opportunities
High-volume transplant centers remain the most attractive downstream customers because system utilization directly determines disposable consumption and economic efficiency. Centers seeking to expand transplant volumes, accept organs from greater distances or increase DCD utilization have the strongest incentive to adopt active perfusion technologies. Organ procurement and recovery organizations also represent an increasingly important channel as transplantation shifts toward centralized recovery, specialist perfusion teams and coordinated logistics.
Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Regional Insights
North America remains the largest and most commercially developed market. The U.S. combines high transplant procedure volumes, established reimbursement pathways, rapid growth in DCD transplantation and broad adoption of integrated organ perfusion and procurement models. TransMedics disclosed that U.S. liver OCS penetration reached 36% and heart penetration 18% in 2025, illustrating that active perfusion has already moved beyond early clinical adoption in selected indications.
Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Competitive Landscape Analysis
The market remains highly concentrated because clinical evidence, regulatory approvals, manufacturing quality systems and transplant-center training create substantial entry barriers. Competition is not based solely on hardware specifications. The leading competitive models include portable multi-organ warm-perfusion platforms integrated with procurement and logistics, liver-focused transport-enabled NMP systems, lung-centered ex vivo perfusion platforms and multi-temperature abdominal perfusion systems capable of supporting several machine-perfusion protocols.
Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Normothermic Organ Perfusion Systems for Transplantation Industry Forecast” looks at past sales and reviews total world Normothermic Organ Perfusion Systems for Transplantation sales in 2025, providing a comprehensive analysis by region and market sector of projected Normothermic Organ Perfusion Systems for Transplantation sales for 2026 through 2032. With Normothermic Organ Perfusion Systems for Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Normothermic Organ Perfusion Systems for Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Normothermic Organ Perfusion Systems for Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Normothermic Organ Perfusion Systems for Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Normothermic Organ Perfusion Systems for Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Normothermic Organ Perfusion Systems for Transplantation and breaks down the forecast by Target Organ, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Normothermic Organ Perfusion Systems for Transplantation.
This report presents a comprehensive overview, market shares, and growth opportunities of Normothermic Organ Perfusion Systems for Transplantation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
Key FindingsIn 2025, the average selling price of commercial normothermic organ perfusion systems worldwide was approximately US$150,000–250,000 per unit.The industry’s overall gross margin remained at approximately 55%–70% in 2025.Liver normothermic perfusion remained the largest commercial organ segment.North America remained the largest value market globally.Organ preservation and transplant preparation remained the largest application segment.
Market Trends
The principal technology trend is the transition from passive preservation toward active organ management. Normothermic perfusion maintains donor organs in a functioning or near-functioning physiological state and creates a time window in which clinicians can observe hemodynamic, metabolic and organ-specific parameters before implantation. This is changing the role of preservation technology from simple time extension to a broader combination of preservation, functional assessment and potentially therapeutic intervention. The commercial direction is also shifting toward organ-specific protocols built on common platform architectures, enabling manufacturers to leverage pumps, monitoring, temperature control, software and disposable technologies across multiple transplant indications.
A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
Market Dynamics
Drivers
The central market driver is the persistent shortage of transplantable donor organs. U.S. transplant activity reached 46,750 solid-organ procedures in 2024, while 167,230 unique patients were present on transplant waiting lists during the year. At the same time, a meaningful proportion of recovered organs remain unused, including 29.3% of recovered kidneys and 11.3% of recovered lungs in 2024. Technologies that can provide functional assessment and improve confidence in marginal or DCD organs therefore have a direct clinical and economic rationale.
Restraints
High equipment and procedure-related costs remain the principal restraint. Commercial NMP requires not only a perfusion console but also organ-specific disposable sets, perfusion solutions, trained personnel and workflow integration. Adoption is consequently concentrated in high-volume transplant centers and healthcare systems capable of supporting specialized operating procedures and reimbursement requirements. Clinical evidence and regulatory approvals are also organ-specific, limiting the ability of manufacturers to transfer commercial success from one organ indication directly to another.
Opportunities
The largest structural opportunity lies in increasing utilization of organs that would otherwise be declined. DCD transplantation, extended-criteria donors, longer-distance donor recovery and objective viability assessment all enlarge the addressable procedure pool without requiring a proportional increase in donor availability. Kidney transplantation represents an especially significant longer-term opportunity because kidney transplant volumes are substantially larger than liver, heart or lung volumes, while current commercial NMP penetration remains limited. Next-generation platforms incorporating automation, continuous data collection and remote monitoring could also reduce operating complexity and extend the technology beyond a relatively small group of specialist centers.
Challenges
The industry must demonstrate that higher preservation costs translate into improved organ utilization, clinical outcomes or transplant-center productivity. Evidence requirements are substantial because performance must be established separately across organs, donor populations and clinical protocols. Operational reliability is also critical: the equipment supports viable donor organs during time-sensitive transplantation processes, so pump failure, temperature instability, disposable-set problems or logistical interruptions can carry unusually high consequences. Scaling manufacturing and clinical-support capacity while maintaining quality systems is therefore a major barrier for emerging suppliers.
Industry Chain Analysis
The upstream industry includes medical-grade pumps, oxygenators, heat exchangers, pressure and flow sensors, temperature-control components, sterile tubing, organ chambers, electronic control systems, embedded software and pharmaceutical-grade perfusion solutions. Because the system operates directly with transplantable organs, suppliers must meet stringent requirements for biocompatibility, sterility, reliability and traceability. Manufacturers typically retain control over core console design, organ-specific disposable circuits, software algorithms and clinical protocols, while sourcing selected pumps, sensors, plastics and electronic components from qualified medical-device supply chains.
The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
Value Chain Analysis
Value creation is concentrated less in conventional hardware manufacturing than in proprietary organ-specific perfusion protocols, clinical evidence, regulatory approvals, disposable ecosystems and transplant-center integration. Reusable consoles can be sold, leased or placed to accelerate installed-base expansion, while recurring disposable perfusion sets and dedicated solutions provide a more scalable source of revenue. XVIVO explicitly identifies disposable sales rather than machines as the primary profitability driver in both its thoracic and abdominal businesses, illustrating the importance of procedure-linked recurring consumption.
The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
Segment Insights
By target organ, liver represents the largest commercial segment, followed by heart and lung, while kidney NMP remains a comparatively early commercial opportunity. Liver NMP has established a particularly strong clinical proposition because viability can be assessed through multiple functional and biochemical indicators and because DCD liver transplantation has expanded rapidly. Heart perfusion represents a high-value application where transport time and DCD utilization are central considerations, while lung perfusion benefits from the established concept of ex vivo lung assessment. Kidney transplantation provides the largest procedure base but currently relies heavily on cold storage and hypothermic machine perfusion, leaving substantial room for NMP development.
By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Downstream Market Opportunities
High-volume transplant centers remain the most attractive downstream customers because system utilization directly determines disposable consumption and economic efficiency. Centers seeking to expand transplant volumes, accept organs from greater distances or increase DCD utilization have the strongest incentive to adopt active perfusion technologies. Organ procurement and recovery organizations also represent an increasingly important channel as transplantation shifts toward centralized recovery, specialist perfusion teams and coordinated logistics.
Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Regional Insights
North America remains the largest and most commercially developed market. The U.S. combines high transplant procedure volumes, established reimbursement pathways, rapid growth in DCD transplantation and broad adoption of integrated organ perfusion and procurement models. TransMedics disclosed that U.S. liver OCS penetration reached 36% and heart penetration 18% in 2025, illustrating that active perfusion has already moved beyond early clinical adoption in selected indications.
Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Competitive Landscape Analysis
The market remains highly concentrated because clinical evidence, regulatory approvals, manufacturing quality systems and transplant-center training create substantial entry barriers. Competition is not based solely on hardware specifications. The leading competitive models include portable multi-organ warm-perfusion platforms integrated with procurement and logistics, liver-focused transport-enabled NMP systems, lung-centered ex vivo perfusion platforms and multi-temperature abdominal perfusion systems capable of supporting several machine-perfusion protocols.
Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Normothermic Organ Perfusion Systems for Transplantation Industry Forecast” looks at past sales and reviews total world Normothermic Organ Perfusion Systems for Transplantation sales in 2025, providing a comprehensive analysis by region and market sector of projected Normothermic Organ Perfusion Systems for Transplantation sales for 2026 through 2032. With Normothermic Organ Perfusion Systems for Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Normothermic Organ Perfusion Systems for Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Normothermic Organ Perfusion Systems for Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Normothermic Organ Perfusion Systems for Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Normothermic Organ Perfusion Systems for Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Normothermic Organ Perfusion Systems for Transplantation and breaks down the forecast by Target Organ, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Normothermic Organ Perfusion Systems for Transplantation.
This report presents a comprehensive overview, market shares, and growth opportunities of Normothermic Organ Perfusion Systems for Transplantation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Target Organ:
- Liver
- Heart
- Lung
- Kidney
- Others
Segmentation by Target Organ:
- Blood-based Perfusate
- Acellular Perfusate
- Others
Segmentation by Donor Type:
- Donation after Brain Death DBD
- Donation after Circulatory Death DCD
- Others
Segmentation by Application:
- Hospitals Transplant Centers
- Organ Procurement Organizations (OPOs)
- Specialty Clinics
- Research Laboratories
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Terumo Corporation
- TransMedics Group, Inc.
- XVIVO Perfusion AB
- Aferetica S.r.l.
- Beijing TsingHan Medical Technology Co., Ltd.
- EBERS Medical Technology S.L.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Normothermic Organ Perfusion Systems for Transplantation market?
- What factors are driving Normothermic Organ Perfusion Systems for Transplantation market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Normothermic Organ Perfusion Systems for Transplantation market opportunities vary by end market size?
- How does Normothermic Organ Perfusion Systems for Transplantation break out by Target Organ, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Normothermic Organ Perfusion Systems for Transplantation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Normothermic Organ Perfusion Systems for Transplantation by Country/Region, 2021, 2025 & 2032
2.2 Normothermic Organ Perfusion Systems for Transplantation Segment by Target Organ
2.2.1 Liver
2.2.2 Heart
2.2.3 Lung
2.2.4 Kidney
2.2.5 Others
2.2.6 Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ
2.2.6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
2.2.6.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Target Organ (2021-2026)
2.2.6.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026)
2.3 Normothermic Organ Perfusion Systems for Transplantation Segment by Target Organ
2.3.1 Blood-based Perfusate
2.3.2 Acellular Perfusate
2.3.3 Others
2.3.4 Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ
2.3.4.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
2.3.4.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Target Organ (2021-2026)
2.3.4.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026)
2.4 Normothermic Organ Perfusion Systems for Transplantation Segment by Donor Type
2.4.1 Donation after Brain Death DBD
2.4.2 Donation after Circulatory Death DCD
2.4.3 Others
2.4.4 Normothermic Organ Perfusion Systems for Transplantation Sales by Donor Type
2.4.4.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type (2021-2026)
2.4.4.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Donor Type (2021-2026)
2.4.4.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Donor Type (2021-2026)
2.5 Normothermic Organ Perfusion Systems for Transplantation Segment by Application
2.5.1 Hospitals Transplant Centers
2.5.2 Organ Procurement Organizations (OPOs)
2.5.3 Specialty Clinics
2.5.4 Research Laboratories
2.5.5 Others
2.5.6 Normothermic Organ Perfusion Systems for Transplantation Sales by Application
2.5.6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2021-2026)
2.5.6.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Normothermic Organ Perfusion Systems for Transplantation Breakdown Data by Company
3.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Company (2021-2026)
3.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company (2021-2026)
3.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Company (2021-2026)
3.2.1 Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Company (2021-2026)
3.2.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company (2021-2026)
3.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Company
3.4 Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Product Location Distribution
3.4.2 Players Normothermic Organ Perfusion Systems for Transplantation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY GEOGRAPHIC REGION
4.1 World Historic Normothermic Organ Perfusion Systems for Transplantation Market Size by Geographic Region (2021-2026)
4.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Normothermic Organ Perfusion Systems for Transplantation Market Size by Country/Region (2021-2026)
4.2.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.4 APAC Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.5 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.6 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Growth
5 AMERICAS
5.1 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country
5.1.1 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
5.1.2 Americas Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
5.2 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
5.3 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region
6.1.1 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region (2021-2026)
6.1.2 APAC Normothermic Organ Perfusion Systems for Transplantation Revenue by Region (2021-2026)
6.2 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
6.3 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Normothermic Organ Perfusion Systems for Transplantation by Country
7.1.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
7.1.2 Europe Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
7.2 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
7.3 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation by Country
8.1.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
8.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
8.3 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation
10.3 Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
10.4 Industry Chain Structure of Normothermic Organ Perfusion Systems for Transplantation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Normothermic Organ Perfusion Systems for Transplantation Distributors
11.3 Normothermic Organ Perfusion Systems for Transplantation Customer
12 WORLD FORECAST REVIEW FOR NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY GEOGRAPHIC REGION
12.1 Global Normothermic Organ Perfusion Systems for Transplantation Market Size Forecast by Region
12.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Region (2027-2032)
12.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Target Organ (2027-2032)
12.7 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Terumo Corporation
13.1.1 Terumo Corporation Company Information
13.1.2 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Terumo Corporation Main Business Overview
13.1.5 Terumo Corporation Latest Developments
13.2 TransMedics Group, Inc.
13.2.1 TransMedics Group, Inc. Company Information
13.2.2 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 TransMedics Group, Inc. Main Business Overview
13.2.5 TransMedics Group, Inc. Latest Developments
13.3 XVIVO Perfusion AB
13.3.1 XVIVO Perfusion AB Company Information
13.3.2 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 XVIVO Perfusion AB Main Business Overview
13.3.5 XVIVO Perfusion AB Latest Developments
13.4 Aferetica S.r.l.
13.4.1 Aferetica S.r.l. Company Information
13.4.2 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Aferetica S.r.l. Main Business Overview
13.4.5 Aferetica S.r.l. Latest Developments
13.5 Beijing TsingHan Medical Technology Co., Ltd.
13.5.1 Beijing TsingHan Medical Technology Co., Ltd. Company Information
13.5.2 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Beijing TsingHan Medical Technology Co., Ltd. Main Business Overview
13.5.5 Beijing TsingHan Medical Technology Co., Ltd. Latest Developments
13.6 EBERS Medical Technology S.L.
13.6.1 EBERS Medical Technology S.L. Company Information
13.6.2 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 EBERS Medical Technology S.L. Main Business Overview
13.6.5 EBERS Medical Technology S.L. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Normothermic Organ Perfusion Systems for Transplantation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Normothermic Organ Perfusion Systems for Transplantation by Country/Region, 2021, 2025 & 2032
2.2 Normothermic Organ Perfusion Systems for Transplantation Segment by Target Organ
2.2.1 Liver
2.2.2 Heart
2.2.3 Lung
2.2.4 Kidney
2.2.5 Others
2.2.6 Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ
2.2.6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
2.2.6.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Target Organ (2021-2026)
2.2.6.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026)
2.3 Normothermic Organ Perfusion Systems for Transplantation Segment by Target Organ
2.3.1 Blood-based Perfusate
2.3.2 Acellular Perfusate
2.3.3 Others
2.3.4 Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ
2.3.4.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
2.3.4.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Target Organ (2021-2026)
2.3.4.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026)
2.4 Normothermic Organ Perfusion Systems for Transplantation Segment by Donor Type
2.4.1 Donation after Brain Death DBD
2.4.2 Donation after Circulatory Death DCD
2.4.3 Others
2.4.4 Normothermic Organ Perfusion Systems for Transplantation Sales by Donor Type
2.4.4.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type (2021-2026)
2.4.4.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Donor Type (2021-2026)
2.4.4.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Donor Type (2021-2026)
2.5 Normothermic Organ Perfusion Systems for Transplantation Segment by Application
2.5.1 Hospitals Transplant Centers
2.5.2 Organ Procurement Organizations (OPOs)
2.5.3 Specialty Clinics
2.5.4 Research Laboratories
2.5.5 Others
2.5.6 Normothermic Organ Perfusion Systems for Transplantation Sales by Application
2.5.6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2021-2026)
2.5.6.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Normothermic Organ Perfusion Systems for Transplantation Breakdown Data by Company
3.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Company (2021-2026)
3.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company (2021-2026)
3.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Company (2021-2026)
3.2.1 Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Company (2021-2026)
3.2.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company (2021-2026)
3.3 Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Company
3.4 Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Product Location Distribution
3.4.2 Players Normothermic Organ Perfusion Systems for Transplantation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY GEOGRAPHIC REGION
4.1 World Historic Normothermic Organ Perfusion Systems for Transplantation Market Size by Geographic Region (2021-2026)
4.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Normothermic Organ Perfusion Systems for Transplantation Market Size by Country/Region (2021-2026)
4.2.1 Global Normothermic Organ Perfusion Systems for Transplantation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.4 APAC Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.5 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Growth
4.6 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Growth
5 AMERICAS
5.1 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country
5.1.1 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
5.1.2 Americas Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
5.2 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
5.3 Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region
6.1.1 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region (2021-2026)
6.1.2 APAC Normothermic Organ Perfusion Systems for Transplantation Revenue by Region (2021-2026)
6.2 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
6.3 APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Normothermic Organ Perfusion Systems for Transplantation by Country
7.1.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
7.1.2 Europe Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
7.2 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
7.3 Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation by Country
8.1.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026)
8.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026)
8.3 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation
10.3 Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
10.4 Industry Chain Structure of Normothermic Organ Perfusion Systems for Transplantation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Normothermic Organ Perfusion Systems for Transplantation Distributors
11.3 Normothermic Organ Perfusion Systems for Transplantation Customer
12 WORLD FORECAST REVIEW FOR NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY GEOGRAPHIC REGION
12.1 Global Normothermic Organ Perfusion Systems for Transplantation Market Size Forecast by Region
12.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Region (2027-2032)
12.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Target Organ (2027-2032)
12.7 Global Normothermic Organ Perfusion Systems for Transplantation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Terumo Corporation
13.1.1 Terumo Corporation Company Information
13.1.2 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Terumo Corporation Main Business Overview
13.1.5 Terumo Corporation Latest Developments
13.2 TransMedics Group, Inc.
13.2.1 TransMedics Group, Inc. Company Information
13.2.2 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 TransMedics Group, Inc. Main Business Overview
13.2.5 TransMedics Group, Inc. Latest Developments
13.3 XVIVO Perfusion AB
13.3.1 XVIVO Perfusion AB Company Information
13.3.2 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 XVIVO Perfusion AB Main Business Overview
13.3.5 XVIVO Perfusion AB Latest Developments
13.4 Aferetica S.r.l.
13.4.1 Aferetica S.r.l. Company Information
13.4.2 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Aferetica S.r.l. Main Business Overview
13.4.5 Aferetica S.r.l. Latest Developments
13.5 Beijing TsingHan Medical Technology Co., Ltd.
13.5.1 Beijing TsingHan Medical Technology Co., Ltd. Company Information
13.5.2 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Beijing TsingHan Medical Technology Co., Ltd. Main Business Overview
13.5.5 Beijing TsingHan Medical Technology Co., Ltd. Latest Developments
13.6 EBERS Medical Technology S.L.
13.6.1 EBERS Medical Technology S.L. Company Information
13.6.2 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
13.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 EBERS Medical Technology S.L. Main Business Overview
13.6.5 EBERS Medical Technology S.L. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Normothermic Organ Perfusion Systems for Transplantation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Normothermic Organ Perfusion Systems for Transplantation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liver
Table 4. Major Players of Heart
Table 5. Major Players of Lung
Table 6. Major Players of Kidney
Table 7. Major Players of Others
Table 8. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 9. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Table 10. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ (2021-2026) & ($ million)
Table 11. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Table 12. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026) & (K US$/Unit)
Table 13. Major Players of Blood-based Perfusate
Table 14. Major Players of Acellular Perfusate
Table 15. Major Players of Others
Table 16. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 17. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Table 18. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ (2021-2026) & ($ million)
Table 19. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Table 20. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026) & (K US$/Unit)
Table 21. Major Players of Donation after Brain Death DBD
Table 22. Major Players of Donation after Circulatory Death DCD
Table 23. Major Players of Others
Table 24. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Donor Type (2021-2026) & (Units)
Table 25. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type (2021-2026)
Table 26. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Donor Type (2021-2026) & ($ million)
Table 27. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type (2021-2026)
Table 28. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Donor Type (2021-2026) & (K US$/Unit)
Table 29. Global Normothermic Organ Perfusion Systems for Transplantation Sale by Application (2021-2026) & (Units)
Table 30. Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2021-2026)
Table 31. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Application (2021-2026) & ($ million)
Table 32. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application (2021-2026)
Table 33. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Application (2021-2026) & (K US$/Unit)
Table 34. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Company (2021-2026) & (Units)
Table 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company (2021-2026)
Table 36. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company (2021-2026)
Table 38. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Company (2021-2026) & (K US$/Unit)
Table 39. Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Producing Area Distribution and Sales Area
Table 40. Players Normothermic Organ Perfusion Systems for Transplantation Products Offered
Table 41. Normothermic Organ Perfusion Systems for Transplantation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Geographic Region (2021-2026) & (Units)
Table 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Geographic Region (2021-2026)
Table 46. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Country/Region (2021-2026) & (Units)
Table 49. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2021-2026)
Table 50. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 53. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country (2021-2026)
Table 54. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 56. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 57. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region (2021-2026) & (Units)
Table 58. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Region (2021-2026)
Table 59. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 61. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 62. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 63. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 65. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 66. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 67. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 69. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 70. Key Market Drivers & Growth Opportunities of Normothermic Organ Perfusion Systems for Transplantation
Table 71. Key Market Challenges & Risks of Normothermic Organ Perfusion Systems for Transplantation
Table 72. Key Industry Trends of Normothermic Organ Perfusion Systems for Transplantation
Table 73. Normothermic Organ Perfusion Systems for Transplantation Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Normothermic Organ Perfusion Systems for Transplantation Distributors List
Table 76. Normothermic Organ Perfusion Systems for Transplantation Customer List
Table 77. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Region (2027-2032) & (Units)
Table 78. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 80. Americas Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Region (2027-2032) & (Units)
Table 82. APAC Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 84. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 86. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Target Organ (2027-2032) & (Units)
Table 88. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Target Organ (2027-2032) & ($ millions)
Table 89. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Application (2027-2032) & (Units)
Table 90. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Terumo Corporation Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 92. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 93. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 94. Terumo Corporation Main Business
Table 95. Terumo Corporation Latest Developments
Table 96. TransMedics Group, Inc. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 97. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 98. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 99. TransMedics Group, Inc. Main Business
Table 100. TransMedics Group, Inc. Latest Developments
Table 101. XVIVO Perfusion AB Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 102. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 103. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 104. XVIVO Perfusion AB Main Business
Table 105. XVIVO Perfusion AB Latest Developments
Table 106. Aferetica S.r.l. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 107. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 108. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 109. Aferetica S.r.l. Main Business
Table 110. Aferetica S.r.l. Latest Developments
Table 111. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 112. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 113. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 114. Beijing TsingHan Medical Technology Co., Ltd. Main Business
Table 115. Beijing TsingHan Medical Technology Co., Ltd. Latest Developments
Table 116. EBERS Medical Technology S.L. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 117. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 118. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 119. EBERS Medical Technology S.L. Main Business
Table 120. EBERS Medical Technology S.L. Latest Developments
Table 1. Normothermic Organ Perfusion Systems for Transplantation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Normothermic Organ Perfusion Systems for Transplantation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liver
Table 4. Major Players of Heart
Table 5. Major Players of Lung
Table 6. Major Players of Kidney
Table 7. Major Players of Others
Table 8. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 9. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Table 10. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ (2021-2026) & ($ million)
Table 11. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Table 12. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026) & (K US$/Unit)
Table 13. Major Players of Blood-based Perfusate
Table 14. Major Players of Acellular Perfusate
Table 15. Major Players of Others
Table 16. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 17. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Table 18. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ (2021-2026) & ($ million)
Table 19. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Table 20. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Target Organ (2021-2026) & (K US$/Unit)
Table 21. Major Players of Donation after Brain Death DBD
Table 22. Major Players of Donation after Circulatory Death DCD
Table 23. Major Players of Others
Table 24. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Donor Type (2021-2026) & (Units)
Table 25. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type (2021-2026)
Table 26. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Donor Type (2021-2026) & ($ million)
Table 27. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type (2021-2026)
Table 28. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Donor Type (2021-2026) & (K US$/Unit)
Table 29. Global Normothermic Organ Perfusion Systems for Transplantation Sale by Application (2021-2026) & (Units)
Table 30. Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2021-2026)
Table 31. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Application (2021-2026) & ($ million)
Table 32. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application (2021-2026)
Table 33. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Application (2021-2026) & (K US$/Unit)
Table 34. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Company (2021-2026) & (Units)
Table 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company (2021-2026)
Table 36. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company (2021-2026)
Table 38. Global Normothermic Organ Perfusion Systems for Transplantation Sale Price by Company (2021-2026) & (K US$/Unit)
Table 39. Key Manufacturers Normothermic Organ Perfusion Systems for Transplantation Producing Area Distribution and Sales Area
Table 40. Players Normothermic Organ Perfusion Systems for Transplantation Products Offered
Table 41. Normothermic Organ Perfusion Systems for Transplantation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Geographic Region (2021-2026) & (Units)
Table 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Geographic Region (2021-2026)
Table 46. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Normothermic Organ Perfusion Systems for Transplantation Sales by Country/Region (2021-2026) & (Units)
Table 49. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2021-2026)
Table 50. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 53. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country (2021-2026)
Table 54. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 56. Americas Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 57. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Region (2021-2026) & (Units)
Table 58. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Region (2021-2026)
Table 59. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 61. APAC Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 62. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 63. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 65. Europe Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 66. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Country (2021-2026) & (Units)
Table 67. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Target Organ (2021-2026) & (Units)
Table 69. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales by Application (2021-2026) & (Units)
Table 70. Key Market Drivers & Growth Opportunities of Normothermic Organ Perfusion Systems for Transplantation
Table 71. Key Market Challenges & Risks of Normothermic Organ Perfusion Systems for Transplantation
Table 72. Key Industry Trends of Normothermic Organ Perfusion Systems for Transplantation
Table 73. Normothermic Organ Perfusion Systems for Transplantation Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Normothermic Organ Perfusion Systems for Transplantation Distributors List
Table 76. Normothermic Organ Perfusion Systems for Transplantation Customer List
Table 77. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Region (2027-2032) & (Units)
Table 78. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 80. Americas Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Region (2027-2032) & (Units)
Table 82. APAC Normothermic Organ Perfusion Systems for Transplantation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 84. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Country (2027-2032) & (Units)
Table 86. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Target Organ (2027-2032) & (Units)
Table 88. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Target Organ (2027-2032) & ($ millions)
Table 89. Global Normothermic Organ Perfusion Systems for Transplantation Sales Forecast by Application (2027-2032) & (Units)
Table 90. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Terumo Corporation Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 92. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 93. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 94. Terumo Corporation Main Business
Table 95. Terumo Corporation Latest Developments
Table 96. TransMedics Group, Inc. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 97. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 98. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 99. TransMedics Group, Inc. Main Business
Table 100. TransMedics Group, Inc. Latest Developments
Table 101. XVIVO Perfusion AB Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 102. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 103. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 104. XVIVO Perfusion AB Main Business
Table 105. XVIVO Perfusion AB Latest Developments
Table 106. Aferetica S.r.l. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 107. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 108. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 109. Aferetica S.r.l. Main Business
Table 110. Aferetica S.r.l. Latest Developments
Table 111. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 112. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 113. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 114. Beijing TsingHan Medical Technology Co., Ltd. Main Business
Table 115. Beijing TsingHan Medical Technology Co., Ltd. Latest Developments
Table 116. EBERS Medical Technology S.L. Basic Information, Normothermic Organ Perfusion Systems for Transplantation Manufacturing Base, Sales Area and Its Competitors
Table 117. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product Portfolios and Specifications
Table 118. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 119. EBERS Medical Technology S.L. Main Business
Table 120. EBERS Medical Technology S.L. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Normothermic Organ Perfusion Systems for Transplantation
Figure 2. Normothermic Organ Perfusion Systems for Transplantation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Normothermic Organ Perfusion Systems for Transplantation Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Normothermic Organ Perfusion Systems for Transplantation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2025)
Figure 10. Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liver
Figure 12. Product Picture of Heart
Figure 13. Product Picture of Lung
Figure 14. Product Picture of Kidney
Figure 15. Product Picture of Others
Figure 16. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ in 2026
Figure 17. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Figure 18. Product Picture of Blood-based Perfusate
Figure 19. Product Picture of Acellular Perfusate
Figure 20. Product Picture of Others
Figure 21. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ in 2026
Figure 22. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Figure 23. Product Picture of Donation after Brain Death DBD
Figure 24. Product Picture of Donation after Circulatory Death DCD
Figure 25. Product Picture of Others
Figure 26. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type in 2026
Figure 27. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type (2021-2026)
Figure 28. Normothermic Organ Perfusion Systems for Transplantation Consumed in Hospitals Transplant Centers
Figure 29. Global Normothermic Organ Perfusion Systems for Transplantation Market: Hospitals Transplant Centers (2021-2026) & (Units)
Figure 30. Normothermic Organ Perfusion Systems for Transplantation Consumed in Organ Procurement Organizations (OPOs)
Figure 31. Global Normothermic Organ Perfusion Systems for Transplantation Market: Organ Procurement Organizations (OPOs) (2021-2026) & (Units)
Figure 32. Normothermic Organ Perfusion Systems for Transplantation Consumed in Specialty Clinics
Figure 33. Global Normothermic Organ Perfusion Systems for Transplantation Market: Specialty Clinics (2021-2026) & (Units)
Figure 34. Normothermic Organ Perfusion Systems for Transplantation Consumed in Research Laboratories
Figure 35. Global Normothermic Organ Perfusion Systems for Transplantation Market: Research Laboratories (2021-2026) & (Units)
Figure 36. Normothermic Organ Perfusion Systems for Transplantation Consumed in Others
Figure 37. Global Normothermic Organ Perfusion Systems for Transplantation Market: Others (2021-2026) & (Units)
Figure 38. Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2025)
Figure 39. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application in 2025
Figure 40. Normothermic Organ Perfusion Systems for Transplantation Sales by Company in 2025 (Units)
Figure 41. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company in 2025
Figure 42. Normothermic Organ Perfusion Systems for Transplantation Revenue by Company in 2025 ($ millions)
Figure 43. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company in 2025
Figure 44. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 47. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 48. APAC Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 49. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 50. Europe Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 51. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 54. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country in 2025
Figure 55. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Figure 56. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 57. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 58. United States Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Region in 2025
Figure 63. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Region (2021-2026)
Figure 64. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 65. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 66. China Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 70. India Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country in 2025
Figure 74. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Figure 75. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 76. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 77. Germany Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 78. France Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 84. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 85. Egypt Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation in 2026
Figure 91. Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
Figure 92. Industry Chain Structure of Normothermic Organ Perfusion Systems for Transplantation
Figure 93. Channels of Distribution
Figure 94. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Forecast by Region (2027-2032)
Figure 95. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Forecast by Target Organ (2027-2032)
Figure 97. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Target Organ (2027-2032)
Figure 98. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Normothermic Organ Perfusion Systems for Transplantation
Figure 2. Normothermic Organ Perfusion Systems for Transplantation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Normothermic Organ Perfusion Systems for Transplantation Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Normothermic Organ Perfusion Systems for Transplantation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2025)
Figure 10. Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liver
Figure 12. Product Picture of Heart
Figure 13. Product Picture of Lung
Figure 14. Product Picture of Kidney
Figure 15. Product Picture of Others
Figure 16. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ in 2026
Figure 17. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Figure 18. Product Picture of Blood-based Perfusate
Figure 19. Product Picture of Acellular Perfusate
Figure 20. Product Picture of Others
Figure 21. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ in 2026
Figure 22. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ (2021-2026)
Figure 23. Product Picture of Donation after Brain Death DBD
Figure 24. Product Picture of Donation after Circulatory Death DCD
Figure 25. Product Picture of Others
Figure 26. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Donor Type in 2026
Figure 27. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type (2021-2026)
Figure 28. Normothermic Organ Perfusion Systems for Transplantation Consumed in Hospitals Transplant Centers
Figure 29. Global Normothermic Organ Perfusion Systems for Transplantation Market: Hospitals Transplant Centers (2021-2026) & (Units)
Figure 30. Normothermic Organ Perfusion Systems for Transplantation Consumed in Organ Procurement Organizations (OPOs)
Figure 31. Global Normothermic Organ Perfusion Systems for Transplantation Market: Organ Procurement Organizations (OPOs) (2021-2026) & (Units)
Figure 32. Normothermic Organ Perfusion Systems for Transplantation Consumed in Specialty Clinics
Figure 33. Global Normothermic Organ Perfusion Systems for Transplantation Market: Specialty Clinics (2021-2026) & (Units)
Figure 34. Normothermic Organ Perfusion Systems for Transplantation Consumed in Research Laboratories
Figure 35. Global Normothermic Organ Perfusion Systems for Transplantation Market: Research Laboratories (2021-2026) & (Units)
Figure 36. Normothermic Organ Perfusion Systems for Transplantation Consumed in Others
Figure 37. Global Normothermic Organ Perfusion Systems for Transplantation Market: Others (2021-2026) & (Units)
Figure 38. Global Normothermic Organ Perfusion Systems for Transplantation Sale Market Share by Application (2025)
Figure 39. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application in 2025
Figure 40. Normothermic Organ Perfusion Systems for Transplantation Sales by Company in 2025 (Units)
Figure 41. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Company in 2025
Figure 42. Normothermic Organ Perfusion Systems for Transplantation Revenue by Company in 2025 ($ millions)
Figure 43. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Company in 2025
Figure 44. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 47. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 48. APAC Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 49. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 50. Europe Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 51. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Revenue 2021-2026 ($ millions)
Figure 54. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country in 2025
Figure 55. Americas Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Figure 56. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 57. Americas Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 58. United States Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Region in 2025
Figure 63. APAC Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Region (2021-2026)
Figure 64. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 65. APAC Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 66. China Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 70. India Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country in 2025
Figure 74. Europe Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Country (2021-2026)
Figure 75. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 76. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 77. Germany Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 78. France Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Target Organ (2021-2026)
Figure 84. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Market Share by Application (2021-2026)
Figure 85. Egypt Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Normothermic Organ Perfusion Systems for Transplantation Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation in 2026
Figure 91. Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
Figure 92. Industry Chain Structure of Normothermic Organ Perfusion Systems for Transplantation
Figure 93. Channels of Distribution
Figure 94. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Forecast by Region (2027-2032)
Figure 95. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Forecast by Target Organ (2027-2032)
Figure 97. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Target Organ (2027-2032)
Figure 98. Global Normothermic Organ Perfusion Systems for Transplantation Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share Forecast by Application (2027-2032)
